MKULQ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MKULQ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Molekule Group's average Accounts Receivable for the three months ended in Jun. 2023 was $1.61 Mil. Molekule Group's Revenue for the three months ended in Jun. 2023 was $13.24 Mil. Hence, Molekule Group's Days Sales Outstanding for the three months ended in Jun. 2023 was 11.11.
The historical rank and industry rank for Molekule Group's Days Sales Outstanding or its related term are showing as below:
During the past 4 years, Molekule Group's highest Days Sales Outstanding was 171.24. The lowest was 11.08. And the median was 137.98.
Molekule Group's Days Sales Outstanding declined from Jun. 2022 (21.85) to Jun. 2023 (11.11).
The historical data trend for Molekule Group's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Molekule Group Annual Data | |||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | |||||
Days Sales Outstanding | - | - | 104.71 | 171.24 |
Molekule Group Quarterly Data | ||||||||||||||
Dec19 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | |
Days Sales Outstanding | Get a 7-Day Free Trial | 21.85 | 31.47 | 24.07 | 5.74 | 11.11 |
For the Pollution & Treatment Controls subindustry, Molekule Group's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Industrial Products industry and Industrials sector, Molekule Group's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Molekule Group's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Accounts Receivable can be measured by Days Sales Outstanding.
Molekule Group's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as
Days Sales Outstanding (A: Dec. 2022 ) | |||||||||
= | Average Accounts Receivable | / | Revenue | * | Days in Period | ||||
= | ( (Accounts Receivable (A: Dec. 2021 ) | + | Accounts Receivable (A: Dec. 2022 )) | / | count ) | / | Revenue (A: Dec. 2022 ) | * | Days in Period |
= | ( (0.177 | + | 0.036) | / | 2 ) | / | 0.227 | * | 365 |
= | 0.1065 | / | 0.227 | * | 365 | ||||
= | 171.24 |
Molekule Group's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:
Days Sales Outstanding (Q: Jun. 2023 ) | |||||||||
= | Average Accounts Receivable | / | Revenue | * | Days in Period | ||||
= | ( (Accounts Receivable (A: Mar. 2023 ) | + | Accounts Receivable (A: Jun. 2023 )) | / | count ) | / | Revenue (A: Jun. 2023 ) | * | Days in Period |
= | ( (1.014 | + | 2.211) | / | 2 ) | / | 13.243 | * | 365 / 4 |
= | 1.6125 | / | 13.243 | * | 365 / 4 | ||||
= | 11.11 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Molekule Group (OTCPK:MKULQ) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Thank you for viewing the detailed overview of Molekule Group's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Ritankar Pal | officer: Chief Operating Officer | 10455 RIVERSIDE DR., PALM BEACH GARDENS FL 33410 |
Jonathan Harris | officer: Chief Commercial Officer | 3000 CLEARVIEW WAY, SAN MATEO CA 94402 |
Bradley A Feld | director | C/O FOUNDRY GROUP, 645 WALNUT ST., BOULDER CO 80302 |
Ryan A Mcintyre | 10 percent owner | |
Seth Levine | 10 percent owner | 1050 WALNUT STREET, SUITE 210, BOULDER CO 80302 |
Fg Next Gp, Llc | 10 percent owner | 1050 WALNUT STREET, SUITE 210, BOULDER CO 80302 |
Foundry Group Next, L.p. | 10 percent owner | C/O FOUNDRY GROUP, 1050 WALNUT STREET, SUITE 219, BOULDER CO 80302 |
Ward Jr Stephen M | director | C/O CARPENTER TECHNOLOGY CORP, PO BOX 14662, READING PA 19612 |
Timothy J Scannell | director | 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002 |
Heather Floyd | director | 1300 CORPORATE CENTER WAY, WELLINGTON FL 33414 |
Thomas P Mccaffrey | director | 1300 CORPORATE CENTER WAY, WELLINGTON FL 33414 |
Lewis C Pell | 10 percent owner | C/O VISION SCIENCES INC, 6 STRATHMORE RD, NATICK MA 01760 |
Michael F Senft | director | 1300 CORPORATE CENTER WAY, WELLINGTON FL 33414 |
Jason Dibona | officer: Chief Executive Officer | 10455 RIVERSIDE DRIVE, PALM BEACH GARDEN FL 33410 |
David Helfet | director | 10455 RIVERSIDE DRIVE, PALM BEACH GARDENS FL 33410 |
From GuruFocus
By sperokesalga sperokesalga • 05-16-2023
By sperokesalga sperokesalga • 05-09-2023
By PurpleRose PurpleRose • 07-27-2022
By sperokesalga sperokesalga • 02-23-2023
By GlobeNewswire GlobeNewswire • 02-27-2023
By sperokesalga sperokesalga • 05-03-2023
By sperokesalga sperokesalga • 04-14-2023
By Stock market mentor Stock market mentor • 01-12-2023
By sperokesalga sperokesalga • 02-17-2023
By Value_Insider Value_Insider • 12-07-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.